Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Mihalov is active.

Publication


Featured researches published by Michael Mihalov.


Digestive Diseases and Sciences | 2001

CASE REPORT: Crohn's Disease Involving the Lung

Arkan I. Alrashid; Russell D. Brown; Michael Mihalov; Marin Sekosan; Bennett J. Pastika; Rama P. Venu

Crohn’s disease is a chronic inflammatory disorder commonly involving the gastrointestinal tract. However, Crohn’s disease may also have several extraintestinal manifestations, such as pyoderma gangrenosum, erythema nodosum, polyarthritis, episcleritis, pericholangitis, and thromboembolism. Pulmonary involvement, although rare, has also been reported in association with inflammatory bowel disease. We report a patient with Crohn’s ileocolitis who presented with multiple pulmonary nodules on chest radiograph, nonproductive cough, and shortness of breath. The diagnosis of pulmonary Crohn’s disease was established by histological examination of the pulmonary nodule following open lung biopsy. The patient was treated with infliximab infusion with a successful clinical outcome and radiographic resolution.


The American Journal of Gastroenterology | 1998

Evaluation of the FlexSure HP whole blood antibody test for diagnosis of Helicobacter pylori infection

Daniel C. Sadowski; Hartley Cohen; Loren Laine; Paul D. Greenberg; Jay L. Goldstein; Michael Mihalov; Alan F Cutler

Objective:Rapid, inexpensive, reliable tests are needed to facilitate the diagnosis of Helicobacter pylori infection. We evaluated the accuracy of the new FlexSure HP whole blood test (SmithKline Diagnostics, Inc.), a rapid, qualitative in-office test for the detection of antibodies to H. pylori utilizing whole blood obtained from a fingerstick.Methods:Five North American sites enrolled patients not previously treated for H. pylori who underwent upper endoscopy. Patients had not received antibiotics, bismuth, or proton pump inhibitors within 4 wk before study enrollment. Bacterial infection was established by the presence of H. pylori in gastric biopsies (minimum of two) or positive rapid urease test of antral tissue. The presence of IgG antibodies was determined using FlexSure HP whole blood tests with blood obtained by fingerstick and FlexSure HP serum and ELISA (HM-CAP) tests with serum obtained from venipuncture.Results:Three hundred ninety-three patients were enrolled (56% male; mean age, 46.8 ± 16.0 yr). H. pylori infection was present in 187 (48%). Compared with the standard of histology and rapid urease test, sensitivity for FlexSure HP whole blood, FlexSure HP serum, and HM-CAP EIA were, respectively, 84%, 90%, and 95% (p < 0.05 compared with FlexSure HP whole blood). There were no statistical differences in specificity or overall accuracy between the three tests.Conclusions:FlexSure HP whole blood demonstrated an accuracy not significantly different from the FlexSure HP serum test but had sensitivity significantly lower than the HM-CAP EIA. FlexSure HP whole blood may be useful for in-office H. pylori diagnosis.


Diseases of The Colon & Rectum | 2002

Superselective mesenteric embolization with microcoils in a porcine model.

Anthony C. Chin; Marc Singer; Michael Mihalov; Herand Abcarian; Jose R. Cintron; Jayant Radhakrishnan; Amit Lamba; Charles A. Owens

AbstractPURPOSE: There is a lack of data regarding the degree of ischemic change that may occur in small and large bowel after superselective arterial embolotherapy with platinum microcoils. The purpose of this study was to gain a clearer understanding of the ischemic complications of superselective embolization of peripheral mesenteric arteries with microcoils by gross and histologic examination of postembolectomy bowel specimens at several time intervals in an adult porcine model. METHODS: Two-millimeter platinum microcoils with fibrils were superselectively deployed into six isolated mesenteric branch vessels in each of nine adult pigs. The animals were observed for two days (n = 3), one month (n = 3), or three months (n = 3) and then killed. At necropsy, intestines were examined for gross abnormalities. Sections of bowel containing microcoils were identified under fluoroscopy, resected, and evaluated histologically. RESULTS: A total of 54 microcoils were deployed into the distal arterial mesentery supplying the jejunum (n = 14), ileum (n = 26), and colon (n = 14) of nine adult pigs. Each animal received six microcoils. There were no clinical complications, and all pigs gained weight during their observation periods. Gross examination of the intestines did not reveal any evidence of acute or chronic ischemia. The coils were found in the distal arterial vasculature of the intestine. Histologic examination revealed mild superficial necrosis of villous tips in several samples; however, this finding is likely related to a fixation artifact rather than ischemic injury. There was no other histologic evidence suggestive of ischemic injury. CONCLUSIONS: Gross and histologic findings after superselective arterial embolotherapy demonstrated minimal changes in the bowel, and there were no significant clinical consequences to the animals. We conclude that transcatheter arterial embolotherapy in pigs is safe and may be applicable in the control of massive lower gastrointestinal hemorrhage in humans.


Applied Immunohistochemistry & Molecular Morphology | 2005

Prognostic significance of DCC and p27Kip1 in colorectal cancer.

James T. Wu; Sanjay Kakar; Richard L. Nelson; Michael Mihalov; Brooke Hayward; Peter B. Gilbert; Luna Ghosh

The progression of colorectal cancer is a multistage process associated with specific molecular alterations. The stepwise accumulation of these multiple genetic mutations progressively results in the acquisition of neoplastic cell behavior. The genetic abnormalities associated with the expression of metastatic phenotype, therefore, may be of prognostic significance in the clinical treatment of colorectal cancer patients. In this study, the immunohistochemical expression of the deleted in colorectal cancer gene (DCC) and p27Kip1 was assessed in 168 paraffin-embedded, formalin-fixed tumors of patients with stage II and III colorectal cancer. Kaplan-Meier survival curves and log-rank statistics were used to analyze survival times after curative primary tumor resection, and Cox proportional hazards models were used to adjust the assessment of demographic and clinical covariates. Loss of DCC or p27Kip1 expression had no influence on survival in patients with stage II or III colorectal cancer. The 5-year survival rates of DCC-positive and DCC-negative tumors were 51.8% and 35.7% (P = 0.40), respectively. The 5-year survival rate of patients with p27Kip1-positive tumors was 47.9%, whereas the rate for patients with p27Kip1-negative tumors was 38.8% (P = 0.68). After adjustment for all evaluated variables, neither DCC or p27Kip1 was found to be a predictor of survival (risk ratio for DCC, 0.98; 95% confidence interval, 0.66-1.56; P = 0.92; risk ratio for p27Kip1, 0.87; 95% confidence interval, 0.58-1.29; P = 0.49). The present study demonstrated that the expression of neither DCC nor p27Kip1 was predictive in poor survival outcome in patients with stage II or III colorectal cancer.


Transplantation | 1998

Comparison of jejunal and ileal surveillance biopsies in a porcine model of intestinal transplantation.

Vandad Raofi; Magali J. Fontaine; Michael Mihalov; Dawn M. Holman; Ty B. Dunn; Joseph M. Vitello; Massimo Asolati; Norman H. Kumins; Enrico Benedetti

BACKGROUND The optimal biopsy site of bowel allografts for rejection surveillance remains controversial. We compared the results of jejunal (JBx) and ileal (IBx) biopsies after bowel transplantation in a porcine model. METHODS Eighteen Yorkshire-Landrace pigs served as donors. Eighteen recipient pigs underwent total enterectomy followed by orthotopic small bowel transplantation with or without the colon. A jejunostomy and a Bishop-Koop ileostomy were constructed for biopsies. Immunosuppression consisted of FK506 (target level 10-15 ng/ml by enzyme immunoparticle assay) and prednisone administered via the jejunostomy. Simultaneous JBx and IBx were performed twice weekly. Acute rejection was graded as mild, moderate, or severe based on previously published criteria. RESULTS Mean overall survival after the transplant was 17.4 days. A total of 162 specimens were collected and evaluated for rejection (JBx, 81; IBx, 81). Acute rejection was detected in 41 JBx cases (50.7%) and 40 IBx cases (49.4%). The presence or absence of rejection was concordant between JBx and IBx in 70 of 81 case pairs (86.4%). Of the 11 discordant case pairs, 6 were JBx positive/IBx negative, whereas 5 were JBx negative/IBx positive. A total of 35 case pairs were synchronously positive, 24 (68.8%) of which demonstrated the same degree of rejection. CONCLUSIONS The correlation between JBx and IBx of bowel allografts in diagnosing the presence of acute rejection is quite good. However, performing IBx alone would have missed about 7.5% of the rejection episodes. Because the early treatment of rejection in bowel transplantation is of paramount importance, in selected cases, biopsies from both the ileum and jejunum should be considered if technically feasible.


British Journal of Haematology | 1998

Successful management of concurrent congenital dyserythropoietic anaemia and autoimmune haemolytic anaemia with splenectomy

Mary Lou Schmidt; Sarita Joshi; Phillip J. DeChristopher; Michael Mihalov; Steven D. Sosler

This first known case of concurrent congenital dyserythropoietic anaemia (CDA) and autoimmune haemolytic anaemia (AIHA) which occurred in a hispanic male and spanned 6 years from the age of 2. Light and electron microscopy of bone marrow erythroblasts and immunophenotyping confirmed CDA; serum/eluate warm autoantibodies and positive direct antiglobulin tests (DAT) associated with severe, episodic anaemias established AIHA. Cytogenetic analysis of bone marrow cells and peripheral blood lymphocytes ascertained sex chromosome aneuploidy (48 XY,+ Y,+ Y). Recurrent, life‐threatening episodes of transfusion‐dependent anaemia refractory to steroids and intravenous immune globulin, were put into stable remission at age 8 years when splenectomy successfully managed both disorders.


Journal of Computer Assisted Tomography | 1999

Ferumoxide-enhanced MRI of sideronecrosis superimposed on genetic hemochromatosis.

Robert I. Aizenstein; Richard Chen; Kent Sato; Michael Mihalov; Howard K. O'Neil

Genetic hemochromatosis is an autosomal recessive disorder characterized by excessive iron absorption from the gut, resulting in increased total body iron stores, multisystem organ dysfunction, and an increased risk of hepatocellular carcinoma. The magnetic susceptibility effects of excess hepatocellular iron generally cause diffuse hepatic signal loss on T2- or T2*-weighted MR images. Although hepatic iron deposition is usually diffuse, focal areas of iron sparing can occur, and, when present, superimposed neoplasm is a consideration. We describe a patient with cirrhosis, hemochromatosis, and multiple small benign relatively hyperintense iron-poor foci consisting of piecemeal sideronecrosis.


Molecular Diagnosis | 2000

HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With Survival

Sanjay Kakar; Nick Puangsuvan; Jane M. Stevens; Romualda Serenas; George Mangan; Shalini Sahai; Michael Mihalov


Digestive Diseases and Sciences | 2001

Crohn's disease involving the lung : Resolution with infliximab

Arkan I. Alrashid; Russell D. Brown; Michael Mihalov; Marin Sekosan; Bennett J. Pastika; Rama P. Venu


Journal of Surgical Oncology | 2000

Correlation of c‐fos, p53, and PCNA expression with treatment outcome in osteosarcoma

Sanjay Kakar; Michael Mihalov; Naresh Chachlani; Luna Ghosh; Helen S. Johnstone

Collaboration


Dive into the Michael Mihalov's collaboration.

Top Co-Authors

Avatar

Enrico Benedetti

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Sanjay Kakar

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Ty B. Dunn

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar

Vandad Raofi

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Luna Ghosh

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Massimo Asolati

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Russell D. Brown

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Arkan I. Alrashid

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Bennett J. Pastika

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Dawn M. Holman

University of Illinois at Chicago

View shared research outputs
Researchain Logo
Decentralizing Knowledge